Design, rationale, and initiation of the Surgical Interventions for Moderate Ischemic Mitral Regurgitation Trial

A report from the Cardiothoracic Surgical Trials Network

Peter K. Smith, Robert E. Michler, Y. Joseph Woo, John H. Alexander, John D. Puskas, Michael K. Parides, Rebecca T. Hahn, Judson B. Williams, John M. Dent, T. Bruce Ferguson, Ellen Moquete, Eric A. Rose, Pierre Pagé, Neal O. Jeffries, Patrick T. O'Gara, Deborah D. Ascheim

Research output: Contribution to journalArticle

18 Citations (Scopus)

Abstract

Objective: Patients with coronary artery disease complicated by moderate ischemic mitral regurgitation have demonstrably poorer outcome than do patients with coronary artery disease but without mitral regurgitation. The optimal treatment of this condition has become increasingly controversial, and a randomized trial evaluating current practices is warranted. Methods: We describe the design and initial execution of the Cardiothoracic Surgical Trials Network Surgical Interventions for Moderate Ischemic Mitral Regurgitation Trial. Results: This is an ongoing prospective, multicenter, randomized, controlled clinical trial designed to test the safety and efficacy of mitral repair in addition to coronary artery bypass grafting in the treatment of moderate ischemic mitral regurgitation. Conclusions: The results of the Cardiothoracic Surgical Trials Network Surgical Interventions for Moderate Ischemic Mitral Regurgitation Trial will provide long-awaited information on controversial therapies for this morbid disease process.

Original languageEnglish (US)
Pages (from-to)111-117
Number of pages7
JournalJournal of Thoracic and Cardiovascular Surgery
Volume143
Issue number1
DOIs
StatePublished - Jan 2012

Fingerprint

Mitral Valve Insufficiency
Coronary Artery Disease
Coronary Artery Bypass
Therapeutics
Randomized Controlled Trials
Safety

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Surgery
  • Pulmonary and Respiratory Medicine

Cite this

Design, rationale, and initiation of the Surgical Interventions for Moderate Ischemic Mitral Regurgitation Trial : A report from the Cardiothoracic Surgical Trials Network. / Smith, Peter K.; Michler, Robert E.; Woo, Y. Joseph; Alexander, John H.; Puskas, John D.; Parides, Michael K.; Hahn, Rebecca T.; Williams, Judson B.; Dent, John M.; Ferguson, T. Bruce; Moquete, Ellen; Rose, Eric A.; Pagé, Pierre; Jeffries, Neal O.; O'Gara, Patrick T.; Ascheim, Deborah D.

In: Journal of Thoracic and Cardiovascular Surgery, Vol. 143, No. 1, 01.2012, p. 111-117.

Research output: Contribution to journalArticle

Smith, PK, Michler, RE, Woo, YJ, Alexander, JH, Puskas, JD, Parides, MK, Hahn, RT, Williams, JB, Dent, JM, Ferguson, TB, Moquete, E, Rose, EA, Pagé, P, Jeffries, NO, O'Gara, PT & Ascheim, DD 2012, 'Design, rationale, and initiation of the Surgical Interventions for Moderate Ischemic Mitral Regurgitation Trial: A report from the Cardiothoracic Surgical Trials Network', Journal of Thoracic and Cardiovascular Surgery, vol. 143, no. 1, pp. 111-117. https://doi.org/10.1016/j.jtcvs.2011.05.006
Smith, Peter K. ; Michler, Robert E. ; Woo, Y. Joseph ; Alexander, John H. ; Puskas, John D. ; Parides, Michael K. ; Hahn, Rebecca T. ; Williams, Judson B. ; Dent, John M. ; Ferguson, T. Bruce ; Moquete, Ellen ; Rose, Eric A. ; Pagé, Pierre ; Jeffries, Neal O. ; O'Gara, Patrick T. ; Ascheim, Deborah D. / Design, rationale, and initiation of the Surgical Interventions for Moderate Ischemic Mitral Regurgitation Trial : A report from the Cardiothoracic Surgical Trials Network. In: Journal of Thoracic and Cardiovascular Surgery. 2012 ; Vol. 143, No. 1. pp. 111-117.
@article{d55d296d91724df88687b8638416aa49,
title = "Design, rationale, and initiation of the Surgical Interventions for Moderate Ischemic Mitral Regurgitation Trial: A report from the Cardiothoracic Surgical Trials Network",
abstract = "Objective: Patients with coronary artery disease complicated by moderate ischemic mitral regurgitation have demonstrably poorer outcome than do patients with coronary artery disease but without mitral regurgitation. The optimal treatment of this condition has become increasingly controversial, and a randomized trial evaluating current practices is warranted. Methods: We describe the design and initial execution of the Cardiothoracic Surgical Trials Network Surgical Interventions for Moderate Ischemic Mitral Regurgitation Trial. Results: This is an ongoing prospective, multicenter, randomized, controlled clinical trial designed to test the safety and efficacy of mitral repair in addition to coronary artery bypass grafting in the treatment of moderate ischemic mitral regurgitation. Conclusions: The results of the Cardiothoracic Surgical Trials Network Surgical Interventions for Moderate Ischemic Mitral Regurgitation Trial will provide long-awaited information on controversial therapies for this morbid disease process.",
author = "Smith, {Peter K.} and Michler, {Robert E.} and Woo, {Y. Joseph} and Alexander, {John H.} and Puskas, {John D.} and Parides, {Michael K.} and Hahn, {Rebecca T.} and Williams, {Judson B.} and Dent, {John M.} and Ferguson, {T. Bruce} and Ellen Moquete and Rose, {Eric A.} and Pierre Pag{\'e} and Jeffries, {Neal O.} and O'Gara, {Patrick T.} and Ascheim, {Deborah D.}",
year = "2012",
month = "1",
doi = "10.1016/j.jtcvs.2011.05.006",
language = "English (US)",
volume = "143",
pages = "111--117",
journal = "Journal of Thoracic and Cardiovascular Surgery",
issn = "0022-5223",
publisher = "Mosby Inc.",
number = "1",

}

TY - JOUR

T1 - Design, rationale, and initiation of the Surgical Interventions for Moderate Ischemic Mitral Regurgitation Trial

T2 - A report from the Cardiothoracic Surgical Trials Network

AU - Smith, Peter K.

AU - Michler, Robert E.

AU - Woo, Y. Joseph

AU - Alexander, John H.

AU - Puskas, John D.

AU - Parides, Michael K.

AU - Hahn, Rebecca T.

AU - Williams, Judson B.

AU - Dent, John M.

AU - Ferguson, T. Bruce

AU - Moquete, Ellen

AU - Rose, Eric A.

AU - Pagé, Pierre

AU - Jeffries, Neal O.

AU - O'Gara, Patrick T.

AU - Ascheim, Deborah D.

PY - 2012/1

Y1 - 2012/1

N2 - Objective: Patients with coronary artery disease complicated by moderate ischemic mitral regurgitation have demonstrably poorer outcome than do patients with coronary artery disease but without mitral regurgitation. The optimal treatment of this condition has become increasingly controversial, and a randomized trial evaluating current practices is warranted. Methods: We describe the design and initial execution of the Cardiothoracic Surgical Trials Network Surgical Interventions for Moderate Ischemic Mitral Regurgitation Trial. Results: This is an ongoing prospective, multicenter, randomized, controlled clinical trial designed to test the safety and efficacy of mitral repair in addition to coronary artery bypass grafting in the treatment of moderate ischemic mitral regurgitation. Conclusions: The results of the Cardiothoracic Surgical Trials Network Surgical Interventions for Moderate Ischemic Mitral Regurgitation Trial will provide long-awaited information on controversial therapies for this morbid disease process.

AB - Objective: Patients with coronary artery disease complicated by moderate ischemic mitral regurgitation have demonstrably poorer outcome than do patients with coronary artery disease but without mitral regurgitation. The optimal treatment of this condition has become increasingly controversial, and a randomized trial evaluating current practices is warranted. Methods: We describe the design and initial execution of the Cardiothoracic Surgical Trials Network Surgical Interventions for Moderate Ischemic Mitral Regurgitation Trial. Results: This is an ongoing prospective, multicenter, randomized, controlled clinical trial designed to test the safety and efficacy of mitral repair in addition to coronary artery bypass grafting in the treatment of moderate ischemic mitral regurgitation. Conclusions: The results of the Cardiothoracic Surgical Trials Network Surgical Interventions for Moderate Ischemic Mitral Regurgitation Trial will provide long-awaited information on controversial therapies for this morbid disease process.

UR - http://www.scopus.com/inward/record.url?scp=83555165066&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=83555165066&partnerID=8YFLogxK

U2 - 10.1016/j.jtcvs.2011.05.006

DO - 10.1016/j.jtcvs.2011.05.006

M3 - Article

VL - 143

SP - 111

EP - 117

JO - Journal of Thoracic and Cardiovascular Surgery

JF - Journal of Thoracic and Cardiovascular Surgery

SN - 0022-5223

IS - 1

ER -